explore -WSS

explore

author：leisure time 2025-08-12 06:44:10 - browse：4

Vertex Pharmaceuticals - sunset — Bill Sikes/AP

Vertex Pharmaceuticals has spent decades trying to develop molecules that reduce pain safely and potently, searching for success in a field its own executives have dubbed a graveyard for drug discovery. Detailed data published Wednesday lent support to that quest, with a pair of company-sponsored clinical trials showing an experimental non-opioid therapy reduced pain after surgery.

The drug, VX-548, blocks signals from pain-sensitive neurons before those electrical messages reach the brain. And in a pair of randomized trials, patients given a high dose of the oral medication after bunion surgery or abdominoplasty (a tummy tuck) reported less pain than those given a placebo. Those taking lower doses of the treatment showed no improvement compared to the placebo group, however.

While the pain reduction measured by these Phase 2 trials was statistically significant, it’s unclear how meaningful the drug’s benefits were to patients, with a commentary accompanying the study describing the treatment effect as “small.” But the study authors noted that participants on a high dose of VX-548 were less likely to prematurely stop their treatment because it wasn’t working than those on placebo or participants given a combination of two common painkillers, acetaminophen and hydrocodone.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Medical experts exlpore how to eliminate bias in clinical algorithms

entertainment

WSS

Eating disorder hotline's move to chatbot carried cost for volunteers

Medical experts exlpore how to eliminate bias in clinical algorithms

Anger, defiance, fear over Supreme Court decision to block student loan forgiveness

Medical experts exlpore how to eliminate bias in clinical algorithms

Synthetic human embryos? Researchers say term is overblown

Diagnostic tests are hitting their mathematical limits

knowledge

explore

explore

As demand for Covid shots wanes, Moderna seeks its next success

Takeda, Janssen join wearable maker to measure scratching

Duchenne breakthrough therapy leaves behind pioneering families

UnitedHealth’s Optum accused of antitrust violations in California

Heart attack and stroke risk calculators need revising

UnitedHealth wins $3.3 billion takeover of Amedisys

DIEP, the 'gold standard' of breast reconstruction, is under threat

Wildfire smoke map: Which US cities are forecast to be impacted by fires burning in Canada

Jerome Adams on the need for new antivirals for Covid

30 years of 'Listening to Prozac'

hotspot

The sun may be out, but guns are not. A lawsuit challenges a new gun ban on Hawaii beaches

What Wagner Group's armed rebellion could mean for Russia's endgame in Ukraine

What Wagner Group's armed rebellion could mean for Russia's endgame in Ukraine

UnitedHealth’s Optum accused of antitrust violations in California

UnitedHealth’s Optum accused of antitrust violations in California

What Wagner Group's armed rebellion could mean for Russia's endgame in Ukraine

entertainment

focus

explore

focus